The UK’s Medicine and Healthcare products Regulatory Agency has already approved the booster dose of AstraZenenca’s Covid-19 vaccine, which is administered in India
One of the very few facilities in India to have this capability, marking a remarkable feat in LifeCell’s expedition to take genome sequencing to the next level in India
Share of government health expenditure in total health expenditure increases to 40.8% (2017-18) from 28.6% (2013-14)
The campaign aims to increase awareness about Tuberculosis as a curable disease and promote early diagnosis.
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
The initiative will engage adolescents and youth of India in decisions about their reproductive health
The company will provide the technical and financial resources to support the study
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
_256_384.jpg)
Both parties are expected to invest a total of US $ 1 million to establish the brand
Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.
Subscribe To Our Newsletter & Stay Updated
